Events

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

12:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

This presentation provides a review of Canine Hypoadrenocorticism (Addison’s Disease); the topics include pathophysiology, signalment, clinical signs, diagnostics, treatment, and monitoring. Cases will be discussed to reinforce your diagnostic confidence.

12:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-894090

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally, a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally, there will be a review of the current literature on the clinical applications of platelet-rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.12:00 PM EST

1 RACE-Approved Credit  

RACE#  27059-973692

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

10:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-900255 

The presenter reviews equine osteoarthritis (OA) and chondroprotective therapies. Focus areas include basic anatomy of the joint, articular cartilage composition and function, pathophysiology of OA including histologic progression, and types of chondroprotective therapies. The types of therapies discussed will include hyaluronate sodium (HA), glycosaminoglycan (PSGAG), and pentosan polysulfate (PPS), which are all currently indicated for OA and/or degenerative joint disease in horses. Additionally a meta-analysis of current research with regards to equine OA treatments will be analyzed.

02:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-1077078

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.

10:00 PM EST

RACE# 27059-869593

1.5 RACE-Approved Credit Hour 
 

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

10:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

This presentation will walk the attendee through the definition of emotional intelligence, accepting the grief journey of others, becoming self aware of your own EI and then boosters to help build EI within themselves. The program should allow the attendee to be able to walk away more comfortable with offering euthanasia to clients and help clients through their time of need.

10:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-1119572

This presentation will be geared toward technicians who are performing dental examinations and dental cleanings. The presenter will discuss charting during a dental cleaning and go over the charting of teeth and other important oral pathology that should be noted.

08:30 PM EST

1 RACE-Approved Credit  

RACE# 27059-1119690

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

12:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

02:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

This presentation will be geared toward technicians who are performing dental examinations and dental cleanings. The presenter will discuss charting during a dental cleaning and go over the charting of teeth and other important oral pathology that should be noted.

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-1119690

The presenter will be covering the routine care that the mare requires throughout the year. The information will cover preparing the mare through anestrus to managing her cycle to conception. Most of the medications and tools used in the breeding shed will be discussed along with the maintenance considerations for the pregnant mare from conception to foaling. The audience will have a better understanding of the changes that a mare goes through to ensure a routine pregnancy. An overview of some of the equipment at the breeding facility will be shared as well as the medications used for the induction of ovulation in mares.

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-898393

This will be an interactive webinar using real life scenarios of various cultural situations that a technician or veterinarian would face in practice. Examples are religious objections, socio-economic problems, Cultural differences. The presentation will go into real-life examples of applying DEI to everyday practice.

08:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-1119654

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

12:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-906349

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

10:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.

02:00 PM EST

RACE# 27059-869593

1.5 RACE-Approved Credit Hour 
 

This technician focused presentation will help technicians build their confidence and emotional intelligence during euthanasia appointments. Technicians will be given tips to deal with owner grief, end of life care and helping pet owners make the decision to help their loved ones cross the rainbow bridge.

09:00 PM EST

RACE# 27059-1120374

1 RACE-Approved Credit Hour 
 

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

7:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

The presenter reviews equine osteoarthritis (OA) and chondroprotective therapies. Focus areas include basic anatomy of the joint, articular cartilage composition and function, pathophysiology of OA including histologic progression, and types of chondroprotective therapies. The types of therapies discussed will include Hyaluronate Sodium (HA), Glycosaminoglycan (PSGAG), Pentosan Polysulfate (PPS) and regenerative autologous blood products currently indicated for OA and/or degenerative joint disease in horses. Additionally a meta-analysis of current research with regard to equine OA treatments will be analyzed.

07:00 PM EST

RACE# 27059-1077078

1 RACE-Approved Credit Hour 
 

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

10:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

This presentation will be a case-based discussion on the importance of skin and otic cytology. The presenter will talk about how to diagnose and manage infections using topical therapy and why having cytology is important to improve positive outcomes.

6:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-1119680

The reasons to sedate our veterinary patients are many. Sedation allows for less stressful handling, positioning, and diagnostic collection for both the patient and veterinary staff. Radiographs, biopsies, IV catheter placement, and potentially even physical exam, nail trimming, ear cleaning and other maintenance procedures can be achieved with more accuracy and safety, and believe it or not, more quickly with appropriate sedation. No one drug possesses every desired quality (reliable sedation, good analgesia, reversibility, minimal side effects) so it is necessary to have a good understanding of many options and combinations so you can choose the right fit for the right situation. A sedation protocol should consider patient personality, comorbities, procedure, and preferred recovery time. The specific drugs and amounts used will depend on several factors. The anesthetist creating the plan will have to evaluate the temperament of the patient, the type of procedure being performed, and the coexisting conditions or contraindications each patient may have.

8:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-1119946

This program will review commonly used sedation protocols and applications in general practice. The speaker will discuss reducing Fear, Anxiety and Stress in the patients and the veterinary team. He will review common methods of pre visit pharmaceuticals, in hospital sedation and examples of protocols that he has successfully used in practice. Finally he will use real-life case examples of sedation and improving FAS for everyone involved.

8:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-111944

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

This program will walk through the clinical signs, diagnosis, and treatment of Hypercortisolism (Cushing's). The speaker will use a case-based approach to discuss new monitoring protocols and treatment possibilities.

8:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-1122012 

The presenter reviews equine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally, a meta-analysis of current research with regard to platelet rich plasma (PRP), autologous conditioned serum (ACS), autologous protein solutions (APS), and alpha 2 macroglobulin will be analyzed.

7:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-924918

This presentation breaks down the complex mechanisms of bisphosphonates as a drug class and their use in managing the clinical signs of navicular syndrome in horses. The second half of the presentation explores the clinical features of non-nitrogenous bisphosphonates including their efficacy and safety in real world field applications.

7:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-963582

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

12:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255